Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

SHE:002275 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,552	1,050	1,058	1,266	1,478	1,362
Short-Term Investments	-	-	43.4	-	-	25.21
Trading Asset Securities	422.29	626.15	304.69	161.24	221.77	355.34
Cash & Short-Term Investments	1,975	1,676	1,406	1,427	1,699	1,742
Cash Growth	49.33%	19.17%	-1.45%	-16.03%	-2.47%	38.93%
Accounts Receivable	475.91	527.3	458.33	542.51	413.03	367.38
Other Receivables	132.81	118.06	4.39	57.58	9.1	13.59
Receivables	608.72	645.36	462.72	600.09	422.13	380.97
Inventory	223.35	208.29	255.96	244.9	284.15	194.37
Other Current Assets	58.04	35.18	71.17	25.06	48.4	62.1
Total Current Assets	2,865	2,565	2,196	2,297	2,454	2,380
Property, Plant & Equipment	1,100	1,111	1,155	1,227	1,313	1,300
Long-Term Investments	112.09	296.89	299.09	132.61	4.21	4.2
Goodwill	5.7	5.7	5.7	5.7	5.7	5.7
Other Intangible Assets	139.34	141.55	153.56	168.28	178.36	166.55
Long-Term Deferred Tax Assets	10.13	10.2	9.33	8.53	11.35	8.83
Long-Term Deferred Charges	100.33	102.44	117.04	125.76	128.8	16.79
Other Long-Term Assets	-	-	-	-	0.03	0.04
Total Assets	4,333	4,232	3,936	3,965	4,096	3,882
Accounts Payable	182.31	191.55	201.38	133.92	180.24	91.56
Accrued Expenses	10.13	184.85	160.61	160.45	123.86	101.77
Short-Term Debt	390.21	325.26	274.2	140.01	251.68	150.08
Current Portion of Long-Term Debt	116.57	103.3	104.54	107.57	33.04	6.31
Current Portion of Leases	-	14.72	14.72	11.81	9.52	9.81
Current Income Taxes Payable	76.27	38.63	25.95	71.79	38.13	27.17
Current Unearned Revenue	12.41	98.06	75.99	170.01	132.79	163.65
Other Current Liabilities	171.32	39.11	36.45	51.38	59.98	38.97
Total Current Liabilities	959.22	995.46	893.83	846.94	829.23	589.31
Long-Term Debt	128.9	121.5	73.92	128.03	226.93	233.35
Long-Term Leases	25.03	28.86	60.95	78.45	87.93	5.14
Long-Term Unearned Revenue	73.27	63.15	89.04	97.85	111.22	94.9
Long-Term Deferred Tax Liabilities	0.08	0.15	-	0.33	0.73	0.58
Other Long-Term Liabilities	13.32	13.32	1.34	-	-	-
Total Liabilities	1,200	1,222	1,119	1,152	1,256	923.27
Common Stock	587.57	587.57	587.57	587.57	590.2	590.2
Additional Paid-In Capital	672.09	672.09	669.24	638.76	685.78	690.25
Retained Earnings	1,886	1,781	1,583	1,573	1,767	1,884
Treasury Stock	-	-	-	-	-204	-204
Comprehensive Income & Other	-12.94	-31.12	-22.72	14.13	0.64	-1.14
Shareholders' Equity	3,133	3,010	2,817	2,813	2,840	2,959
Total Liabilities & Equity	4,333	4,232	3,936	3,965	4,096	3,882
Total Debt	660.71	593.63	528.33	465.88	609.1	404.68
Net Cash (Debt)	1,314	1,082	877.86	961.07	1,090	1,338
Net Cash Growth	46.07%	23.27%	-8.66%	-11.86%	-18.50%	34.86%
Net Cash Per Share	2.25	1.85	1.50	1.63	1.90	2.32
Filing Date Shares Outstanding	587.57	587.57	587.57	587.57	575.27	575.27
Total Common Shares Outstanding	587.57	587.57	587.57	587.57	575.27	575.27
Working Capital	1,906	1,569	1,302	1,450	1,625	1,791
Book Value Per Share	5.33	5.12	4.79	4.79	4.94	5.14
Tangible Book Value	2,988	2,863	2,658	2,639	2,656	2,787
Tangible Book Value Per Share	5.08	4.87	4.52	4.49	4.62	4.84
Buildings	-	1,000	993.15	997.12	1,053	1,029
Machinery	-	773.59	775.06	76.86	76.54	563.54
Construction In Progress	-	69.54	21.24	61.66	105.26	299.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.